Table 3.
Clinical factors associated with health-related quality of lifea
Total MLHFQ score |
P-value | Physical MLHFQ score |
P-value | Emotional MLHFQ score |
P-value | |
---|---|---|---|---|---|---|
Duration of CHF | 0.224 | 0.010 | 0.223 | 0.011 | 0.151 | 0.085 |
Previous MI | ||||||
Yes | 52.0±19.0 | 0.373 | 25.5±10.3 | 0.684 | 11.2±6.2 | 0.418 |
No | 49.6±19.4 | 25.3±9.0 | 10.4±6.6 | |||
Previous AP | ||||||
Yes | 51.6±19.0 | 0.325 | 25.8±9.9 | 0.344 | 10.8±6.6 | 0.796 |
No | 48.6±19.6 | 24.7±8.7 | 10.5±6.4 | |||
Hypertension | ||||||
Yes | 49.1±19.9 | 0.130 | 24.8±9.4 | 0.255 | 10.1±6.5 | 0.084 |
No | 54.0±17.1 | 26.9±9.5 | 12.2±6.4 | |||
Diabetes mellitus | ||||||
Yes | 49.8±17.9 | 0.904 | 24.0±8.9 | 0.180 | 11.3±6.7 | 0.365 |
No | 50.6±19.9 | 25.9±9.6 | 10.3±6.4 | |||
Number of comorbidities | −0.053 | 0.538 | −0.045 | 0.604 | −0.039 | 0.649 |
NYHA class | ||||||
I or II | 39.3±18.2 | <0.001 | 19.3±9.8 | <0.001 | 8.5±5.5 | 0.023 |
III or IV | 54.7±18.0 | 27.7±8.2 | 11.5±6.6 | |||
LVEF (%) | ||||||
≥40 | 49.3±18.7 | 0.661 | 25.1±9.1 | 0.699 | 10.7±6.4 | 0.568 |
<40 | 51.5±19.9 | 25.5±9.9 | 10.4±6.6 | |||
Depressive symptoms | ||||||
Yes | 57.9±17.6 | <0.001 | 28.5±8.9 | <0.001 | 13.1±6.4 | <0.001 |
No | 40.9±17.1 | 21.4±8.6 | 7.5±5.0 | |||
Cognitive impairment | ||||||
Yes | 53.8±20.7 | 0.030 | 26.6±9.8 | 0.062 | 12.1±7.2 | 0.022 |
No | 46.7±17.0 | 24.0±8.9 | 9.1±5.2 | |||
Length of hospital stay | 0.198 | 0.021 | 0.162 | 0.060 | 0.199 | 0.020 |
Notes:
Univariate analysis. HRQOL was assessed using the Minnesota Living with Heart Failure questionnaire; higher scores represent more impaired HRQOL. Data are presented as the mean ± standard deviation, Pearson’s product-moment correlation coefficient, or Spearman’s rank correlation coefficient.
Abbreviations: MLHFQ, Minnesota Living with Heart Failure questionnaire; CHF, chronic heart failure; MI, myocardial infarction; AP, angina pectoris; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; HRQOL, health-related quality of life.